Clinical Trials Browser

Phase 2 × Gastrointestinal Malignancies × Clear all

NCT05229588 2025-08-15

Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations

Phase 2 Completed

Gastrointestinal

Gastrointestinal Malignancies